Exhibit 107
Calculation of Table
Form S-8
(Form Type)
Artiva Biotherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Offering Note |
|
Security |
|
Security Class Title |
|
Fee Calculation Rule |
|
Amount Registered |
|
Proposed Maximum Offering Price Per |
|
Maximum Offering Price |
|
Fee Rate |
|
Amount of |
|
|
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|||||||
(1) |
|
Equity |
|
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2024 Equity Incentive Plan |
|
Other |
|
1,229,777 |
|
$5.43 |
|
$6,677,689.11 |
|
0.00013810 |
|
$922.19 |
(2) |
|
Equity |
|
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2024 Employee Stock Purchase Plan |
|
Other |
|
245,955 |
|
$4.62 |
|
$1,136,312.10 |
|
0.00013810 |
|
$156.93 |
(3) |
|
Equity |
|
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2025 Inducement Plan |
|
Other |
|
600,000 |
|
$5.43 |
|
$3,258,000.00 |
|
0.00013810 |
|
$449.93 |
|
|
|
|
|
|
|
||||||||||
|
|
Total Offering Amounts |
|
— |
|
$11,072,001.21 |
|
— |
|
$1,529.04 |
||||||
|
|
|
|
|
|
|
||||||||||
|
|
Total Fee Offsets |
|
— |
|
— |
|
— |
|
— |
||||||
|
|
|
|
|
|
|
||||||||||
|
|
Net Fee Due |
|
— |
|
— |
|
— |
|
$1,529.04 |
||||||